{
    "name": "TipsForAcne source link check",
    "description": "Monthly check of every outside source link on TipsForAcne.com. Dead sources are replaced with the same document at its new address, or with an Internet Archive copy labelled as archived on the page. Nothing is removed silently.",
    "url": "https://tipsforacne.com/sources/#source-check",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "method": "Every link in published articles and pages is requested each month. A link counts as dead only after two different requests both get 404/410 or no DNS. Sites that block automated requests are opened by hand in a browser; any not yet opened are counted as manual_check.",
    "fields": {
        "checked": "Date of the latest check (UTC).",
        "unique_links": "Distinct outside URLs linked from published content.",
        "ok": "Links confirmed working (automatically or by hand).",
        "dead_found": "Links confirmed dead this check.",
        "manual_check": "Links whose site blocks automated checks and that are still waiting for a hand check.",
        "fixed_this_month": "Each dead link and what replaced it: moved = same document at its new address; archived = Internet Archive copy, labelled on the page.",
        "history": "One row per monthly check."
    },
    "checked": "2026-10-04",
    "pages_scanned": 110,
    "unique_links": 517,
    "ok": 514,
    "dead_found": 3,
    "manual_check": 0,
    "hand_checked": 53,
    "fixed_this_month": [
        {
            "url": "https://clinics.elsevier.es/pt-adult-acne-versus-adolescent-acne-articulo-S0365059622002240",
            "new_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9837660/",
            "how": "moved",
            "page": "posts/396",
            "date": "2026-10-03"
        },
        {
            "url": "https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trial-snapshot-winlevi",
            "new_url": "https://web.archive.org/web/20250618185025/https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trial-snapshot-winlevi",
            "how": "archived",
            "page": "posts/369",
            "date": "2026-10-03"
        },
        {
            "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "new_url": "https://web.archive.org/web/20260313023910/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "how": "archived",
            "page": "posts/292",
            "date": "2026-10-03"
        },
        {
            "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "new_url": "https://web.archive.org/web/20260313023910/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "how": "archived",
            "page": "posts/284",
            "date": "2026-10-03"
        },
        {
            "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "new_url": "https://web.archive.org/web/20260313023910/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "how": "archived",
            "page": "posts/280",
            "date": "2026-10-03"
        },
        {
            "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "new_url": "https://web.archive.org/web/20260313023910/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "how": "archived",
            "page": "posts/278",
            "date": "2026-10-03"
        },
        {
            "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "new_url": "https://web.archive.org/web/20260313023910/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "how": "archived",
            "page": "posts/252",
            "date": "2026-10-03"
        },
        {
            "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "new_url": "https://web.archive.org/web/20260313023910/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-hypersensitivity-reactions-certain-over-counter",
            "how": "archived",
            "page": "posts/250",
            "date": "2026-10-03"
        }
    ],
    "history": [
        {
            "checked": "2026-10-04",
            "unique_links": 517,
            "ok": 514,
            "dead_found": 3,
            "fixed": 3,
            "manual_check": 0
        }
    ]
}